Chengdu Kanghua Biological Products Co., Ltd.
SHZ: 300841.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Hongbo Wu
- Employees
- 620
- Headquarters
- Chengdu, China
- IPO year
- 2020
- Market cap
- CN¥7.5B
- Website
- https://www.kangh.com
Loading 300841…
Loading profile data…Frequently asked questions about 300841
What does Chengdu Kanghua Biological Products Co., Ltd. (300841.SZ) do?
Chengdu Kanghua Biological Products Co., Ltd. engages in the research, development, production, sale, and technical service of biological products in China. It offers group ACYW135 meningococcal polysaccharide vaccines; and freeze-dried human diploid cell rabies vaccines. The company also develops seasonal influenza vaccines without preservative...
Where does 300841.SZ trade?
Chengdu Kanghua Biological Products Co., Ltd. (300841.SZ) trades on the Shenzhen Stock Exchange.
What sector is 300841.SZ in?
Chengdu Kanghua Biological Products Co., Ltd. (300841.SZ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Chengdu Kanghua Biological Products Co., Ltd.?
Hongbo Wu is the chief executive officer of Chengdu Kanghua Biological Products Co., Ltd. (300841.SZ).
Where is Chengdu Kanghua Biological Products Co., Ltd. headquartered?
Chengdu Kanghua Biological Products Co., Ltd. is headquartered in China.
Does 300841.SZ pay a dividend?
Yes — Chengdu Kanghua Biological Products Co., Ltd. (300841.SZ) paid a trailing twelve-month dividend of CNY 1.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 300841.SZ go public?
Chengdu Kanghua Biological Products Co., Ltd. (300841.SZ) completed its initial public offering in 2020.